Category: News

CADTH supports the reimbursement of Botox for Chronic Migraine

Good News! CADTH supports the reimbursement of Botox for Chronic Migraine Botox was approved by Health Canada in 2011, but reimbursement by public payers was difficult to obtain. Following an updated recommendation from CADTH, access is likely to improve for Canadians with Chronic Migraine. What…

Will Aimovig be covered by public drug plans in Canada?

We have been following the arrival of CGRP antibodies (Aimovig, Emgality) in Canada. Below are a few comments on access and coverage. What is the drug coverage system like in Canada? Canadians pay their medications either through private insurance companies (with plans often linked with…

Global Patient Advocacy Committee

GPAC = Global Patient Advocacy Committee People working together to improve migraine care and understanding. GPAC is a group of physicians, patient advocates and representants from institutions, associations and industries related to the migraine field. Countries represented included Brazil, Japan, Spain, Italy, France, US, UK,…

CGRP antibodies for migraine

CGRP antibodies are coming to Canada and are stirring a lot of interest from the medical community. Patients also have many questions about these new treatments. Migraine Canada has created a handout to provide basic information. Have a look, and if you are a health care…

20th Anniversary Headache & Migraine Forum

Ontario Health Charity (London) promoting 20th Anniversary Headache & Migraine Forum – supporters Canadian Headache Society, Allergan Canada, electroCore LLC, Via Rail, others Saturday, June 13, 2015 Our professional voluntary health charity is hosting our 20th Anniversary event in Downtown London on Saturday, June 13/15….